Acupressure for COVID-19 Related Quality of Life and Stress

Quality of Life Clinical Trial

Official title:

Randomized Controlled Trial of Acupressure for Health-Related Quality of Life and Perception of Stress Among Health Care Providers During the COVID-19 Pandemic

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04472559
• Other study ID #: 20-000773
• Status: Completed
• Phase: N/A
• Start date: June 16, 2021
• Est. completion date: September 1, 2022

Study information

• Verified date: October 2022
• Source: University of California, Los Angeles
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is being conducted to evaluate the efficacy of acupressure in promoting health and well-being among healthcare workers during the COVID-19 pandemic. The investigators hypothesize that providing participants with a remote and standardized self-acupressure training program will improve HRQOL and the perception of stress. In the event that the study demonstrates acupressure to be safe and effective for this indication, the training could be scaled up and deployed at low-cost nationally and internationally.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 164
• Est. completion date: September 1, 2022
• Est. primary completion date: June 24, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All adult patients (18 years of age and over) who are health care providers according to self-report will be eligible for participation with the exception of subjects meeting exclusion criteria as below.

Exclusion Criteria:

• Exclusion criteria includes subjects who are physically unable to participate (e.g., from severe arthritis) or cognitively unable to participate (e.g., from dementia) will be excluded. Patients unable to provide their own informed consent will be excluded. Patients under the age of 18 years will be excluded. Pregnant women will be excluded. Patients who have previous training in acupressure will be excluded.

Related Conditions & MeSH terms

• Quality of Life
• Stress

Intervention

Behavioral:
• Self-acupressure
Self-acupressure

Locations

Country	Name	City	State
United States	UCLA	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health Related Quality of Life	SF-12v2	8 weeks
Primary	Perception of stress	Perceived Stress Scale	8 weeks